Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Aortic and Vascular Graft Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Aortic and Vascular Graft Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Aortic and Vascular Graft Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Aortic and Vascular Graft Devices Overview
4 Products under Development
4.1 Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
4.2 Aortic and Vascular Graft Devices - Pipeline Products by Territory
4.3 Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
4.4 Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
4.5 Aortic and Vascular Graft Devices - Ongoing Clinical Trials
5 Aortic and Vascular Graft Devices - Pipeline Products under Development by Companies
5.1 Aortic and Vascular Graft Devices Companies - Pipeline Products by Stage of Development
5.2 Aortic and Vascular Graft Devices – Companies Pipeline Products by Stage of Development
6 Aortic and Vascular Graft Devices Companies and Product Overview
6.15.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview
7 Aortic and Vascular Graft Devices- Recent Developments
7.1 Apr 24, 2024: Meihua International Medical Technologies Reports 2023 Financial Year Results
7.2 Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings
7.3 Oct 31, 2023: Meihua International Medical Technologies, Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device
7.4 Oct 16, 2023: Humacyte Publishes Preclinical Results Showing Human Acellular Vessel (HAV) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model
7.5 Oct 15, 2023: Shanghai Kindly Medical Instruments Co. Notice of 2023 First Extraordinary General Meeting
7.6 Oct 05, 2023: Shanghai Kindly Medical Instruments Co. Announces 2022 Annual Report
7.7 Oct 02, 2023: Swedish Personalized Tissue Graft Company Verigraft Reports Promising Interim Results From a First-In-Man Study in Patients With Deep Venous Insufficiency at 2023 Cell & Gene Meeting on the Mesa
7.8 Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
7.9 Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
7.1 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
Table 2: Aortic and Vascular Graft Devices - Pipeline Products by Territory
Table 3: Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
Table 4: Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
Table 33: Trillium - Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)
Table 34: Trillium - Prospective, Single Arm, Multi-center, First-in-human (FIH) Study to Assess the Safety and Performance of the Innoventric Trillium Stent Graft for the Treatment of Severe Tricuspid Regurgitation (TR)
Table 35: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Merit Medical Systems Inc - Ongoing Clinical Trials Overview
Table 39: WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients: The WAVE Study
Table 40: Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Aortic Vascular Intervention Device - Product Status
Table 56: VEST - A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
Table 60: Verigraft AB - Ongoing Clinical Trials Overview
Table 61: P-TEV - Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency
Table 62: Glossary
2.2. List of Figures
Figure 1: Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
Figure 2: Aortic and Vascular Graft Devices - Pipeline Products by Territory
Figure 3: Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
Figure 4: Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date